Published in Tuberculosis Week, June 29th, 2009
"Their chemical structures were confirmed by H-1-nuclear magnetic resonance (NMR) and electrospray mass spectrometry (ES-MS) spectral data, and elemental analysis. The in vitro antimycobacterial evaluation was performed according to the Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF) antituberculosis drug discovery program," wrote B. Kocyigitkaymakcioglu and colleagues, Marmara...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Tuberculosis Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.